Obesity and Metabolic Health

Why is obesity medically important?

Obesity affects multiple organ systems and is associated with increased long-term morbidity and mortality. Excess adipose tissue is not biologically inert. It functions as an endocrine organ, releasing inflammatory mediators and hormones that influence glucose metabolism, vascular function and lipid regulation.

Over time, this contributes to insulin resistance and increased cardiometabolic risk. Obesity is strongly associated with:

• Type 2 diabetes and prediabetes
• Hypertension
• Abnormal cholesterol levels
• Coronary heart disease and stroke
• Non-alcoholic fatty liver disease
• Obstructive sleep apnoea
• Polycystic ovary syndrome and subfertility

Risk generally increases progressively with higher BMI and greater central fat distribution. Early identification of metabolic risk factors allows intervention before irreversible complications develop.

What causes obesity?

Obesity develops when energy intake chronically exceeds energy expenditure, but the underlying drivers are complex and multifactorial. It is rarely explained by a single cause.

Common contributing factors include:

Energy regulation and appetite signalling

Body weight is regulated by a complex neurohormonal system involving:

• Leptin
• Ghrelin
• Insulin
• Hypothalamic appetite pathways

Disruption to these signalling pathways can alter hunger, satiety and metabolic rate. Over time, the body may defend a higher weight “set point”, making sustained weight loss biologically challenging.

Environmental and dietary factors

Modern food environments contribute significantly:

• High availability of ultra-processed foods
• Energy-dense, low-satiety diets
• Sugary drinks
• Large portion sizes
• Frequent snacking patterns

These factors promote excess caloric intake, often without proportional satiety.

Physical inactivity

Reduced occupational movement, sedentary work and low baseline activity decrease total daily energy expenditure. Even modest reductions in daily movement can contribute to gradual long-term weight gain.

Genetic predisposition

Obesity has a strong heritable component. Multiple genes influence:

• Appetite regulation
• Fat distribution
• Energy expenditure
• Reward pathways linked to food

Genetic predisposition does not make weight gain inevitable, but it may increase vulnerability within an obesogenic environment.

Endocrine and medical conditions

Certain medical conditions can contribute to weight gain, including:

• Hypothyroidism
• Cushing’s syndrome
• Polycystic ovary syndrome
• Insulin resistance

These are less common causes but should be considered where symptoms suggest an underlying hormonal disorder.

Medications

Some prescribed medications may promote weight gain, including:

• Certain antidepressants
• Antipsychotics
• Insulin and sulfonylureas
• Corticosteroids
• Some antihypertensives

Weight gain related to medication should be reviewed with a GP before making any changes.

Sleep, stress and psychological factors

Chronic sleep deprivation alters ghrelin and leptin balance, increasing appetite and cravings. Persistent stress elevates cortisol, which may promote central fat deposition.

Emotional eating, trauma and mood disorders can also influence eating behaviour and weight regulation.

When should you seek medical assessment?

Not all weight gain requires medical intervention. However, assessment may be appropriate where there are additional risk factors or concerning features.

You may benefit from GP review if you have a BMI above 30, or above 27 with associated medical conditions such as hypertension or dyslipidaemia. Medical review is also advisable if weight gain is rapid, unexplained, or accompanied by symptoms such as fatigue, menstrual changes, or features suggestive of endocrine disturbance.

Individuals with a strong family history of type 2 diabetes or cardiovascular disease may also benefit from metabolic screening, even in the absence of overt symptoms.

A structured clinical assessment allows evaluation of overall cardiometabolic risk, consideration of secondary causes, and discussion of appropriate management strategies.

What investigations may be recommended?

Investigations are guided by clinical history and risk profile rather than BMI alone.

Where appropriate, a GP may recommend blood tests to assess:

• Glycaemic control, including HbA1c
• Lipid profile
• Liver function
• Thyroid function
• Kidney function

These tests help identify insulin resistance, early diabetes, dyslipidaemia or fatty liver disease, which may otherwise remain asymptomatic in early stages.

The aim of investigation is not simply to label weight, but to understand metabolic health.

How is obesity managed?

Management is individualised and depends on overall risk, coexisting conditions and patient goals.

Lifestyle intervention remains foundational. Sustainable nutritional change, structured physical activity and improved sleep patterns are central to long-term success. Even modest weight reduction, typically 5 to 10 percent of body weight, can significantly reduce blood pressure, improve glycaemic control and lower cardiovascular risk.

In selected cases, prescription medication may be considered in line with UK clinical guidance. Medication is typically used as an adjunct to lifestyle intervention rather than a replacement for it.

For individuals with severe obesity and significant comorbidities, referral to specialist services, including bariatric assessment, may be appropriate.

Obesity is increasingly recognised as a chronic relapsing condition. Long-term management and realistic goal setting are often more effective than short-term, rapid weight loss strategies.eps to be taken to reduce long-term risk, even before medication is needed.

---

Further Reading and Hub Links

Visit our Diabetes and Endocrine Health hub or browse more health topics in the AccessGP Knowledge Base.